GlassScriptPhysician profile
Emily Y Gerbie
NPI 1588058580
$4,960.74
in general payments reported to CMS, 2019-2025
39 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,222 · 2021: $282 · 2022: $955 · 2023: $599 · 2024: $752 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,501.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,264.21 | 2019-2025 | |
| Astellas Pharma US INC | $416.58 | 2021-2025 | Xtandi |
| Abbvie INC. | $406.65 | 2022-2025 | |
| Procept Biorobotics Corporation | $247.96 | 2022-2025 | Aquabeam System |
| Astrazeneca Pharmaceuticals LP | $227.43 | 2022-2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $179.42 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $176.73 | 2023-2025 | Gemtesa |
| Pfizer INC. | $175.30 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $161.88 | 2022-2025 | Lynparza, Keytruda |
| Olympus America INC. | $149.46 | 2022-2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $144.87 | 2022-2025 | |
| Janssen Biotech, INC. | $140.79 | 2023-2025 | Erleada |
| Boston Scientific Corporation | $116.68 | 2021-2025 | Rezum Generator, Lithovue, Advantage System |
| Urovant Sciences INC | $115.01 | 2022 | |
| Urogen Pharma, INC. | $93.20 | 2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Gerbie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.